RECITALSExclusive Development and Commercialization Agreement • November 5th, 2001 • Molichem Medicines Inc • Pharmaceutical preparations • New York
Amendment No. 1 to the Exclusive Development and Commercialization Agreement, dated as of May 11, 2001 Between InterMune, Inc. and Molichem R&D, Inc.Exclusive Development and Commercialization Agreement • August 14th, 2002 • Molichem Medicines Inc • Pharmaceutical preparations
Our signatures below approve this document as Amendment No. 1 (“Amendment”) to that certain Exclusive Development and Commercialization Agreement, dated as of May 11, 2001, between InterMune, Inc. and MoliChem R&D, Inc. (the “Agreement”). All capitalized terms that are not defined in this Amendment No. 1 shall have the meaning ascribed to such capitalized terms in the Agreement.
ContractExclusive Development and Commercialization Agreement • March 6th, 2019
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
